CVRx Inc (CVRX NASDAQ) stock market data APIs
$6.7318
0.28(4.2%)
as of September 17, 2025
Try our APIs with
free plan!
CVRx Inc Financial Data Overview
Price chart is built with
Anychart
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Prev. Close
6.7318
Open
7.0163
High
7.0952
Low
6.4812
52 wk Range
4.2993-18.55
Market Cap
182 M
Shares Outstanding
26 073 K
Revenue
54 652 K
EPS
-0.57
Beta
1.224
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with CVRx Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CVRx Inc data using free add-ons & libraries
Get CVRx Inc Fundamental Data
CVRx Inc Fundamental data includes:
- Net Revenue: 54 652 K
- EBITDA: -50 374 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-04
- EPS/Forecast: -0.52
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CVRx Inc News
New
CVRx outlines $55M-$57M revenue target for 2025 as sales force transition nears completion
Earnings Call Insights: CVRx (CVRX) Q2 2025 MANAGEMENT VIEW * Kevin Hykes, President and CEO, announced "total revenue of $13.6 million in the second quarter, a 15% increase over the same quarter ...
CVRx GAAP EPS of -$0.57 misses by $0.05, revenue of $13.6M beats by $0.38M
* CVRx press release [https://seekingalpha.com/pr/20188110-cvrx-reports-second-quarter-2025-financial-and-operating-results] (NASDAQ:CVRX [https://seekingalpha.com/symbol/CVRX]): Q2 GAAP EPS of -$0....
CVRx Inc (NASDAQ:CVRX) Reports Q2 2025 Earnings: Revenue Slightly Beats Estimates While EPS Misses
CVRx Inc (NASDAQ:CVRX [https://www.chartmill.com/stock/quote/CVRX/profile]), a commercial-stage medical device company specializing in neuromodulation solutions for cardiovascular diseases, reported i...
Steris (STE) Earnings Expected to Grow: Should You Buy?
The market expects Steris (STE) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook is impo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
